Partners: Corporations

GlaxoSmithKline Biologicals

rule

Asian Rotavirus Surveillance Program - Phase II

To establish active sentinel hospital surveillance and disease burden studies for rotavirus gastroenteritis in Asia.

  • Funding Partners: GlaxoSmithKline Biologicals, Program for Appropriate Technology in Health (PATH)
  • Program Partners: National Center for Infectious Diseases, CDC
Related Information: